Holocene Advisors

Holocene Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Holocene Advisors’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$68.1M	Buy
2023 Q1	$27.7M	Buy